Literature DB >> 10926287

Functional mitochondrial heterogeneity in heteroplasmic cells carrying the mitochondrial DNA mutation associated with the MELAS syndrome (mitochondrial encephalopathy, lactic acidosis, and strokelike episodes).

A Bakker1, C Barthélémy, P Frachon, D Chateau, D Sternberg, J P Mazat, A Lombès.   

Abstract

Most mitochondrial DNA (mtDNA) alterations associated with human disorders are heteroplasmic, i.e. mutant mtDNA molecules coexist with normal ones within the cell. We addressed the possibility of intermitochondrial exchanges through histologic analyses of cybrid clones with increasing proportion of the MELAS (A3243G) mtDNA transfer RNA point mutation. MtDNA-dependent cytochrome c oxidase activity and protein composition as well as mitochondrial membrane potential appeared heterogeneous in individual cells from clonal heteroplasmic cell populations on the basis of confocal and electron microscopy. The number of defective cells increased with increasing mutation load. We conclude that in the presence of a heteroplasmic mtDNA mutation in the cell type that we studied, intermitochondrial molecular exchanges cannot provide an efficient even distribution of the complementing molecules such as wild-type mtDNA, transfer RNA, or protein. Mitochondria in these heteroplasmic cells cannot, therefore, be considered a single functional unit.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10926287     DOI: 10.1203/00006450-200008000-00005

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  5 in total

1.  Mitochondrial fusion in human cells is efficient, requires the inner membrane potential, and is mediated by mitofusins.

Authors:  Frédéric Legros; Anne Lombès; Paule Frachon; Manuel Rojo
Journal:  Mol Biol Cell       Date:  2002-12       Impact factor: 4.138

2.  Renal cell carcinoma in a pediatric patient with an inherited mitochondrial mutation.

Authors:  Surasak Sangkhathat; Takeshi Kusafuka; Akihiro Yoneda; Seika Kuroda; Yukichi Tanaka; Mio Tanaka; Norio Sakai; Masahiro Fukuzawa
Journal:  Pediatr Surg Int       Date:  2005-10-20       Impact factor: 1.827

Review 3.  Intracellular quality control of mitochondrial DNA: evidence and limitations.

Authors:  Dmitry A Knorre
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2019-12-02       Impact factor: 6.237

4.  Rapamycin drives selection against a pathogenic heteroplasmic mitochondrial DNA mutation.

Authors:  Ying Dai; Kangni Zheng; Joanne Clark; Russell H Swerdlow; Stefan M Pulst; James P Sutton; Leslie A Shinobu; David K Simon
Journal:  Hum Mol Genet       Date:  2013-09-18       Impact factor: 6.150

5.  Correction of the consequences of mitochondrial 3243A>G mutation in the MT-TL1 gene causing the MELAS syndrome by tRNA import into mitochondria.

Authors:  Olga Z Karicheva; Olga A Kolesnikova; Tom Schirtz; Mikhail Y Vysokikh; Anne-Marie Mager-Heckel; Anne Lombès; Abdeldjalil Boucheham; Igor A Krasheninnikov; Robert P Martin; Nina Entelis; Ivan Tarassov
Journal:  Nucleic Acids Res       Date:  2011-06-30       Impact factor: 16.971

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.